AMA acting ‘cheap’ over Qld pharmacy trial


Dr Bav Manoharan makes a motion at the AMA's 2019 AGM. Image AMA Media via Twitter.
Dr Bav Manoharan makes a motion at the AMA's 2019 AGM. Image AMA Media via Twitter.
The Australian Medical Association has passed an urgency motion that the organisation should call for the Queensland pharmacy prescribing trial to be stopped immediately At the AMA’s Annual General Meeting, held during its national conference in Brisbane, Dr Bav Manoharan, director at the AMA and its Queensland branch, moved “That Federal Council and AMA Federal

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Call for funding, GP support for pharmacy testing
Next Pharmacist investment welcomed